- Home
- FMY vs NRXS Comparison
FMY vs NRXS Comparison
Compare FMY & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | FMY | NRXS |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | 21 |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 44.7M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FMY | NRXS |
|---|---|---|
| Price | $12.13 | $4.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 10.1K | ★ 869.4K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 6.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,362,320.00 |
| Revenue This Year | N/A | $31.05 |
| Revenue Next Year | N/A | $137.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.89 |
| 52 Week Low | $10.71 | $1.33 |
| 52 Week High | $12.17 | $6.20 |
Technical Indicators
Market Signals| Indicator | FMY | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 61.91 | 75.83 |
| Support Level | $11.83 | $2.63 |
| Resistance Level | $12.00 | $4.25 |
| Average True Range (ATR) | 0.09 | 0.40 |
| MACD | 0.03 | 0.17 |
| Stochastic Oscillator | 83.33 | 90.91 |
Price Performance
Historical ComparisonAbout FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).